Marco Spagnolo: Catheter-Based LAAC vs. Oral Anticoagulation
Marco Spagnolo, Associate Editor at EuroIntervention Case Reports, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Cardiology, adding:
“We tried to bring some clarity to the growing body of evidence comparing catheter-based left atrial appendage closure (LAAC) with oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation.
Beyond the numerical results summarized in this slide, I believe that two key factors – one preprocedural and one postprocedural – may be central to translating these findings into clinical practice and defining priorities for future research:
- Patient selection (presence, nature, and severity of OAC intolerance or contraindications);
- The antithrombotic strategy adopted after LAAC.
Both warrant prospective investigation in dedicated randomized clinical trials.
The full manuscript is available in JAMA Cardiology
Congratulations to my co-authors, Claudio and Kamil, and special thanks to Prof. Capodanno for his mentorship.”
Title: Catheter-Based Left Atrial Appendage Closure vs Oral Anticoagulation in Patients With Atrial FibrillationA Systematic Review and Meta-Analysis
Authors: Claudio Laudani, Kamil Bujak, Daniele Giacoppo, Simone Finocchiaro, Luigi Cutore, Maria Sara Mauro, Pietro Redigolo, Placido Maria Mazzone, Giacinto Di Leo, Francesco Nasisi, Marco Spagnolo, Antonio Greco, Davide Capodanno
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 21, 2026, 13:52Negar Asdaghi: Could Cilostazol Improve Hematoma Clearance After ICH
-
Oct 21, 2026, 10:33Karen Schreiber: Beyond Clinical Outcomes – The Voices of Women with APS
-
Oct 21, 2026, 10:11Tau Braun: Clots Through the Copper-Zinc Model
-
Oct 21, 2026, 09:55Cristina Figueroa Villalba: Celebrating Excellence in Transfusion Medicine
-
Oct 21, 2026, 09:43Ahmad Gharehbaghian: How Can Blood Supplies Be Sustained During a Crisis?
-
Oct 21, 2026, 09:30Adrián Dante De Angelis: Research That Opens New Possibilities for Recurrent iTTP
-
Oct 21, 2026, 09:13Jarod Horobin: Blood 2026 – Connecting Science and People
-
Oct 21, 2026, 08:35Raeeda Gheewala: VTE in Athletes – Risks Beyond the Playing Field
-
Oct 21, 2026, 08:29Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis